Screening tool does not cut distress in cancer patients

Screening tool does not cut distress in cancer patients
Distress monitoring and needs assessment using the Distress Thermometer and Problem List does not appear to be cost-effective in improving mood states in cancer patients, according to research published online Sept. 3 in the Journal of Clinical Oncology.

(HealthDay)—Distress monitoring and needs assessment using the Distress Thermometer and Problem List (DT&PL) does not appear to be cost-effective in improving mood states in cancer patients, according to research published online Sept. 3 in the Journal of Clinical Oncology.

William Hollingworth, Ph.D., of the University of Bristol in the United Kingdom, and colleagues randomly assigned 220 patients starting radiotherapy or chemotherapy to an intervention group (112 patients) or a control group (108 patients). The effect of a 25-minute intervention with the DT&PL on patient outcomes and health care costs was assessed.

The researchers found that, among the patients receiving the intervention, one-third reported high levels of distress; most patients reported physical (84 percent) or emotional (56 percent) problems. No evidence of an effect of the DT&PL was observed for psychological distress, quality of life, or health care costs. Fewer than 3 percent of patients in either group were referred to a clinical psychologist.

"Needs can be identified using short, simple, and inexpensive screening tools," writes the author of an accompanying editorial. "However, results need to be followed-up with further assessment of specific needs and appropriate referral and treatment."

More information: Abstract
Full Text (subscription or payment may be required)
Editorial

Journal information: Journal of Clinical Oncology

Copyright © 2013 HealthDay. All rights reserved.

Citation: Screening tool does not cut distress in cancer patients (2013, September 7) retrieved 23 April 2024 from https://medicalxpress.com/news/2013-09-screening-tool-distress-cancer-patients.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Dexamethasone beats placebo for cancer-related fatigue

 shares

Feedback to editors